Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door ...

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

When HHS Secretary Robert Kennedy Jr. terminated nearly $500 million in mRNA research last week, he didn’t just cripple our ...

Canceling federal mRNA vaccine projects threatens much more than pandemic response, an expert at Michigan State University ...

The director of the National Institutes of Health, Jay Bhattacharya, explained why the federal government wound up $500 ...

It may be time to rethink certain genetic mutations associated with two devastating neurodegenerative disorders—amyotrophic ...

Antipathy from figures close to Trump toward mRNA technology, which underlies Moderna’s products and pipeline, has weighed on ...

It ain’t what you don’t know that gets you into trouble. It’s what you know for sure that just ain’t so.” Mark Twain’s quip ...

AN2 Therapeutics completes dosing first single ascending dose cohort in phase 1 first-in-human clinical trial of oral AN2-502998 for Chagas disease: Menlo Park, California Thursda ...

Q2 2025 Earnings Call Transcript August 11, 2025 Arcturus Therapeutics Holdings Inc. beats earnings expectations. Reported EPS is $-0.34, expectations were $-1.11. Operator: Good day, everyone, and ...